Figure 1.
Kaplan-Meier analysis of (A) overall survival, (B) cumulative incidence of transplant-related mortality and (C) disease relapse after transplantation according to the donor NKG2D polymorphism in patients with standard-risk disease. Patients with donors with the HNK1 haplotype had better overall survival and lower transplant-related mortality. Donor haplotype had no significant impact on disease relapse.